Class IIOngoing

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment recall

FDA recall D-0417-2025 · initiated Mar 5, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Details

Product: La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
Recalling company: L'Oreal USA
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA
Initiated: Mar 5, 2025
FDA report date: May 21, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0417-2025 ↗

← All drug recalls